Fd Chain Gene 3' Terminus Modification for Antibody Secretion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing Fab-type antibodies using yeast as a host face challenges with low productivity and the risk of endoplasmic reticulum stress when using strong promoters to enhance production, leading to inefficient and costly processes.

Innovation Solution

Ligating a nucleotide sequence encoding 1 to 10 amino acid residues to the 3′-terminus of the Fd or L chain nucleotide sequence in yeast, allowing for improved secretion and production of Fab-type antibodies without the need for high-activity promoters, thereby reducing endoplasmic reticulum stress and production costs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If a strong promoter with high activity is used to enhance antibody production, then the production amount of Fab-type antibody increases, but endoplasmic reticulum stress occurs and productivity decreases

Engineering Contradiction:
Improveproduction amount of Fab-type antibodyVSAvoidproductivity of Fab-type antibody
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent introduces a nucleotide sequence encoding a specific amino acid sequence (Asp-Lys-Thr-His-Thr) as an intermediary element at the 3'-terminus of the Fd or L chain gene. This intermediary sequence acts as a regulatory module that enhances antibody secretion without requiring high-activity promoters, thereby increasing production amount while maintaining productivity by avoiding endoplasmic reticulum stress.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If a strong promoter with high activity is used to enhance antibody production, then the production amount of Fab-type antibody increases, but endoplasmic reticulum stress is given to cell mass

Engineering Contradiction:
Improveproduction amount of Fab-type antibodyVSAvoidendoplasmic reticulum stress
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent introduces a nucleotide sequence encoding a specific amino acid sequence (Asp-Lys-Thr-His-Thr) as an intermediary element at the 3'-terminus of the Fd or L chain gene. This intermediary sequence acts as a regulatory module that enhances antibody secretion without requiring high-activity promoters, thereby increasing production amount while maintaining productivity by avoiding endoplasmic reticulum stress.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of manufacture

If conventional yeast host is used for protein production, then production cost decreases, but carbon source influences the product and productivity is low

Engineering Contradiction:
Improveproduction costVSAvoidproductivity of Fab-type antibody
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent changes the genetic parameter of the yeast host by introducing a specific nucleotide sequence at the 3'-terminus of the antibody genes. This genetic modification enables conventional yeast to achieve high productivity without requiring special carbon sources, thereby maintaining low production costs while significantly improving antibody production levels.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS10570197B2Fd chain gene or L chain gene capable of increasing secretion amount of fab-type antibody
Publication Date: 2020.02.25 KANEKA CORP

AI summary

It is an object of the present invention to provide a method for producing a low-molecular-weight antibody such as a Fab-type antibody, using yeast as a host, wherein the method is able to produce the low-molecular-weight antibody with high productivity. According to the present invention, there is provided a gene comprising a nucleotide sequence encoding an amino acid or an amino acid sequence capable of increasing the secretion amount of a Fab-type antibody at the 3′-terminus of a nucleotide sequence encoding the amino acid sequence of the Fd chain or L chain of an antibody.